top of page

OPACE - COPD Trial

OPACE is a clinical trial funded by NIHR and conducted by University of Cambridge and Cambridge University Hospitals NHS Foundation Trust (CUH). OPC is collaborating with CUH to help with the recruitment of practices as patient identification centres (PICs) for the trial.

​

All PICs will receive full support from OPC to identify, invite and refer patients to the trial. No further practice involvement is required as all study visits are performed remotely and by a trial centralised team. 

PIC (Practice Identification Centre Model) 

PIC.new.png

Trial Design

TD.png

PIC Practice Role – Supported by OPC 

PIC Role.png

Patient Involvement

  • Study invitation from Practice 

  • Phone call from HCP and remote COPD review 

  • Enrolled and randomized to medication (azithromycin or placebo for 20 months) 

  • Monitored and followed up by phone or video (up to 6 times) 

  • Patient reported outcomes, so no major tests or hospital visits 

Benefits for Patients

  • Patients can take part entirely from home 

  • Free trial medication is delivered to patients’ homes 

  • More healthcare professional follow -ups from hospital team 

  • Amazon Gift Voucher 

Microscope in Laboratory

To join OPACE, please contact us  at OPACE@optimumpatientcare.org   Tel: 01223 967 855​

​

OPACE Clinical Trial Unit

bottom of page